Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Market Cap	316.31M
Revenue (ttm)	362.81M
Net Income (ttm)	23.99M
Shares Out	141.84M
EPS (ttm)	0.17
PE Ratio	13.19
Forward PE	n/a
Dividend	0.11 (4.93%)
Ex-Dividend Date	Jun 25, 2025

Volume	120,800
Average Volume	38,375
Open	2.230
Previous Close	2.230
Day's Range	2.230 - 2.230
52-Week Range	1.980 - 3.060
Beta	0.05
RSI	53.74
Earnings Date	May 22, 2025

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, engages in the manufacturing and trading of generic drugs. It operates through three segments: Manufacturing, Trading, and Investment Holding. The company manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. It also manufactures aquatic, cosmetic, and biotechnology products, as well as traditional herbal medicines, food supplements, over...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 1,381
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: YSPSAH

Financial Performance

In 2024, KLSE:YSPSAH's revenue was 368.66 million, an increase of 3.85% compared to the previous year's 355.00 million. Earnings were 26.69 million, a decrease of -28.48%.